Genomics

Dataset Information

FOXM1 variant contributes to gefitinib resistance via activating wnt/β-catenin signal pathway in non-small cell lung cancer patients


ABSTRACT: FOXM1 variant contributes to gefitinib resistance via activating wnt/β-catenin signal pathway in non-small cell lung cancer patients

PROVIDER: PRJNA828031 | ENA |

REPOSITORIES: ENA